100 related articles for article (PubMed ID: 29980609)
1. Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80.
Neuss S; Bartel Y; Born C; Weil S; Koch J; Behrends C; Hoffmeister M; Steinle A
J Immunol; 2018 Aug; 201(4):1275-1286. PubMed ID: 29980609
[TBL] [Abstract][Full Text] [Related]
2. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses.
Klimosch SN; Bartel Y; Wiemann S; Steinle A
Blood; 2013 Oct; 122(14):2380-9. PubMed ID: 23929856
[TBL] [Abstract][Full Text] [Related]
3. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.
Welte S; Kuttruff S; Waldhauer I; Steinle A
Nat Immunol; 2006 Dec; 7(12):1334-42. PubMed ID: 17057721
[TBL] [Abstract][Full Text] [Related]
4. Peptide mimicry of AICL inhibits cytolysis of NK cells by blocking NKp80-AICL recognition.
Huang H; Zheng X; Tian Z; Sun R
Immunol Invest; 2010; 39(6):587-97. PubMed ID: 20653426
[TBL] [Abstract][Full Text] [Related]
5. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.
Rückrich T; Steinle A
J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447
[TBL] [Abstract][Full Text] [Related]
6. NKp80 defines and stimulates a reactive subset of CD8 T cells.
Kuttruff S; Koch S; Kelp A; Pawelec G; Rammensee HG; Steinle A
Blood; 2009 Jan; 113(2):358-69. PubMed ID: 18922855
[TBL] [Abstract][Full Text] [Related]
7. Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1.
Akatsuka A; Ito M; Yamauchi C; Ochiai A; Yamamoto K; Matsumoto N
Int Immunol; 2010 Sep; 22(9):783-90. PubMed ID: 20663776
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity.
Dennehy KM; Klimosch SN; Steinle A
J Immunol; 2011 Jan; 186(2):657-61. PubMed ID: 21149606
[TBL] [Abstract][Full Text] [Related]
9. Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia.
Deng G; Zheng X; Zhou J; Wei H; Tian Z; Sun R
J Biol Chem; 2015 Sep; 290(37):22474-84. PubMed ID: 26198633
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
Thomas M; Boname JM; Field S; Nejentsev S; Salio M; Cerundolo V; Wills M; Lehner PJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1656-61. PubMed ID: 18230726
[TBL] [Abstract][Full Text] [Related]
11. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
12. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes.
Spreu J; Kuttruff S; Stejfova V; Dennehy KM; Schittek B; Steinle A
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5100-5. PubMed ID: 20194751
[TBL] [Abstract][Full Text] [Related]
13. Differentially induced expression of C-type lectins in activated lymphocytes.
Eichler W; Ruschpler P; Wobus M; Drössler K
J Cell Biochem Suppl; 2001; Suppl 36():201-8. PubMed ID: 11455585
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.
Biassoni R; Fogli M; Cantoni C; Costa P; Conte R; Koopman G; Cafaro A; Ensoli B; Moretta A; Moretta L; De Maria A
J Immunol; 2005 May; 174(9):5695-705. PubMed ID: 15843571
[TBL] [Abstract][Full Text] [Related]
15. AICL: a new activation-induced antigen encoded by the human NK gene complex.
Hamann J; Montgomery KT; Lau S; Kucherlapati R; van Lier RA
Immunogenetics; 1997; 45(5):295-300. PubMed ID: 9038101
[TBL] [Abstract][Full Text] [Related]
16. NKp80 Defines a Critical Step during Human Natural Killer Cell Development.
Freud AG; Keller KA; Scoville SD; Mundy-Bosse BL; Cheng S; Youssef Y; Hughes T; Zhang X; Mo X; Porcu P; Baiocchi RA; Yu J; Carson WE; Caligiuri MA
Cell Rep; 2016 Jul; 16(2):379-391. PubMed ID: 27373165
[TBL] [Abstract][Full Text] [Related]
17. Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex.
Bartel Y; Bauer B; Steinle A
Front Immunol; 2013 Nov; 4():362. PubMed ID: 24223577
[TBL] [Abstract][Full Text] [Related]
18. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.
Brooks AG; Posch PE; Scorzelli CJ; Borrego F; Coligan JE
J Exp Med; 1997 Feb; 185(4):795-800. PubMed ID: 9034158
[TBL] [Abstract][Full Text] [Related]
19. p46, a novel natural killer cell-specific surface molecule that mediates cell activation.
Sivori S; Vitale M; Morelli L; Sanseverino L; Augugliaro R; Bottino C; Moretta L; Moretta A
J Exp Med; 1997 Oct; 186(7):1129-36. PubMed ID: 9314561
[TBL] [Abstract][Full Text] [Related]
20. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
